Gene Therapy Development 2024

13 - 14 June 2024 | London, UK

Thank you to all attendees, speakers, and sponsors of Gene Therapy Development 2024 for making this event a success.

You may be interested in Cell & Gene 2024.

Event Page - Hero Banner 6

Explore Gene Therapy Development 2024: Unlocking Future Insights in Gene Therapy Development Research

The 3rd Annual Gene Therapy Development Congress unites leading experts working in gene therapy development to provide a comprehensive journey through the latest advances and challenges, with the aim of accelerating gene therapy production.

3rd Annual Gene Therapy Development Congress

Gain an end-to-end outlook on the entire journey of gene therapy development, with 5 tracks exploring the discovery, clinical trial, manufacturing, and commercialisation of gene therapies.

Tackle the latest challenges in our interactive sessions featuring panel discussions and roundtables, addressing pressing issues such as vector design, gene engineering, preparing for regulatory changes, and more

Benefit from real-world case studies presented by industry experts, including insights into how to navigate regulatory submission, as well as operationalising clinical trials

Acquire practical solutions to overcome obstacles in the development and production of gene therapies, with opportunities to meet with and hear from vendor companies

Agenda at a Glance


  • Day One | Track 1: Vector Development
  • Day One | Track 2: Gene Therapy Manufacturing & Supply Chain 
  • Day One | Track 3: Pre-clinical and Clinical Therapeutic Development
  • Day Two | Track 1: Gene Therapy Analytics
  • Day Two | Track 2: Emerging Targets and Gene Editing Tools and Strategies

What to Expect

250

leading pharma, biotech, & academic delegates

15
hours of presentations, discussions & interactive content
7
hours of networking breaks, including speed networking & refreshments
80
hours of pre-arranged 1-2-1 meetings, facilitating business growth
Interactive Presentations
Exhibition Hall
Networking Drinks
Poster Display
Event App Swapcard

Networking & knowledge-sharing is at the heart of what we do. Alongside the innovative programme, attendees can engage in a variety of event features and make the most of participation in a range of experiences

  • Engaging Thought Leadership

    Over 45 dynamic interactive discussions, roundtables, and presentations curated with insights from top industry leaders and experts
  • Global Technological Showcase

    An international exhibition showcasing cutting-edge technologies and services from leading providers in the scientific field.
  • Networking Emphasis

    Unparalleled networking opportunities, including speed networking sessions, a vibrant drinks reception, and informal gatherings to foster meaningful connections
  • Innovative Poster Displays

    Inspiring poster displays and presentations unveiling the latest breakthroughs from emerging biotech, pharma, and academic institutions

Companies Represented Include

Meet Our Expert Speakers

Gene Therapy Development 2024 again brings together a panel of prominent leaders and scientists, sharing new case studies, innovative, data and industry outlooks.

Below are some of our featured speakers:

Alba Guijarro Belmar
Head of Vector Development,
Sania Therapeutics
Alberto del Rio Espinola
Director,
GentiBio Inc
Amin Hajitou
Professor,
Imperial College London
Charlotte Smerdon
Senior Director, Clinical Operations,
Purespring Therapeutics
Giandomenico Turchiano
Associate Director,
UCL/AstraZeneca
James Norton
Director analytical development,
MeiraGTx
Jane Kinghorn
Director Translational Research Office,
University College London
Johnson Varghese
Head of Analytical Development,
BeamTx
Lilian Hook
Director Cell, Apheresis and Gene Therapies,
NHS Blood and Transplant
Nathalie Cartier-Lacave
Senior Vice President Neurobiology,
AskBio
Breech Conrad Odu
Process Development Scientist,
Merck Life Sciences
Chrysanthi Sitmalidou
Scientist II,
Orchard Therapeutics
Claudio Mussolino
Group Leader,
Medical Center - University of Freiburg
De Cupere Vinciane
Technical Lead,
UCB
Elina Hessels
Associate Director Analytical Platforms,
uniQure
Ellina Allais
Regulatory Affairs Senior Director,
Cellectis S.A.
Eugenio Macchiarulo
Director of PD/MSAT,
Barinthus Biotherapeutics
Khalid Saeed
Senior Scientist,
AstraZeneca
Koval Smith
Snr Manager,
Orchard
Lily li
lead scientist,
aviadobio
Mana Yen
Gene Therapies - Global Head of Health Systems and Policy at Novartis Gene Therapies.,
Novartis
Michel Degueldre
Lead GT Biophysical Sciences,
UCB
Nina Kotsopoulou
Chief Technology Officer,
Xap Therapeutics
Pamela Whalley
Associate Director of Chemistry, Manufacturing and Control,
Complement Therapeutics
Patricia Lareo
Value Chain Capability Lead Gene Therapy,
Roche
Peter Pechan
Head of Vector Biology and Discovery,
UCB
Yen Choo
Founder & Chairman; Associate Professor of Stem Cell Science and Regenerative Medicine,
Plasticell; Lee Kong Chian School of Medicine Science
Yu-Tsan (Richard) Liu
Sr. Scientist,
UCB Pharma

Interested in Sponsoring?

Oxford Global’s range of sponsorship opportunities are highly effective in enabling market immersion and visibility, with direct access to clients and potential customers.

Learn more

Latest Resources

Enhancing Gene Editing Efficiency: Multi-Tailed mRNA Integration in CRISPR-Cas9 Systems

A study conducted by the Broad Institute and the Massachusetts Institute of Technology (MIT) demonstrated that when multi-tailed mRNAs were integrated into a CRISPR-Cas9 system they proved to be more efficient gene editors than unmodified mRNA.

Post-Event Proceedings – Gene Therapy Development & Manufacturing 2023

Concise and insightful summaries of presentations delivered by prominent thought leaders at Gene Therapy Development & Manufacturing 2023.

Curing HIV with cell & gene therapy?

It is now possible to live a long and near normal life with HIV, but what is the likelihood of a permanent cure?

Proactive Approaches to Cell Culture Media and Process Control Strategies

Merck invests $25 million in a Kansas cell culture media plant, aiming to meet rising demand for advanced therapeutics while aligning with sustainability goals.

In Conversation With… Sophie Mountcastle, Network Manager, Innovation Hubs for Gene Therapies

Here, we discuss the crucial role of a collaborative network for gene therapy development across the UK and some of the successes seen to date.

How Current and New Technologies can Overcome Challenges in Adherent Scale-Up

Plan Your Visit

ILEC Conference Centre
47 Lillie Rd London SW6 1UD United Kingdom

By Underground

Sitting at the edge of zone 1, West Brompton and Earls Court stations are both within walking distance giving easy access to all central districts of London and Heathrow Airport. Transport for London tube map.

By Car

ILEC is a quarter of a mile (400m) from the A4, providing easy access to the M4, M5 and M40.

By Air

Heathrow (LHR): 21 km - Approximately 30 minutes in light traffic. You can also reach the airport directly by London Underground, on the Piccadilly line. Gatwick (LGW): 45 Km - Approximately an hour in light traffic. It is 40 minutes by train from West Brompton station via Clapham Junction. Direct shuttle available with Easy Bus. London City (LCY): 21 km - Approximately 45 minutes in light traffic.

Parking

There is a car park adjacent to ILEC with 140 parking bays. The parking is NOT managed by ILEC so spaces cannot be reserved and may become full during busy events. Guests and delegates can benefit from preferential parking rates as follows: Up to 2 hours £7 Up to 4 hours £11 Up to 6 hours £14 Up to 9 hours £16 (£21 for non-residents) Up to 12 hours £20 (£26 for non-residents) Up to 24 hours (overnight) £26

Oxford Global have secured a number of bedrooms at ibis London Earls Court at a reduced rate:

 

Wednesday 12th June 2024 – £176, breakfast included

Thursday 13th June 2024 – £176, breakfast included

 

Should you wish to book a room, please click here.

 

The final cut-off date to book bedrooms is Monday 27th May 2024 – any bookings after this date are subject to availability and rates. Please note, that any cancellations within 14 days prior to arrival are subject to cancellation charges.

 

Additionally, we kindly remind all attendees to only book their accommodation if they are registered for the event. This ensures that accommodations are available for those who have officially secured their attendance.

We are closely monitoring the official guidance from health authorities, local governments, and the World Health Organization in order to support the health and well-being of our global community. The health and safety of our staff, customers and clients remains our number one priority.

As we continue to move forward with hosting our events in-person in 2024, we’ve added a series of Health & Safety guidelines and precautions in order to prepare for event safety. We carry out risk assessments for all our events to evaluate fundamental considerations and how to cover multiple risk scenarios.

Oxford Global has learned that third-party companies (recently EHotel Services, Business Travel Management/btravelmanagement and Exhibitors Hotel Reservations Services) are targeting conference attendees with a fraudulent hotel booking scheme.

Please note that none of these third-party companies are associated with Oxford Global in any way, nor have Oxford Global authorised them to use their names or trademarks on information they send out to attendees.

If you are contacted by a third-party company by phone or email using Oxford Global’s name or the name of Gene Therapy Development 2024 and offering accommodation services, we urge exhibitors and attendees to proceed with extreme caution before signing anything sent by these companies or entering into any conversation or replying to any emails sent from these third-party companies.

Register Your Interest

Submit your details and a member of our team will be in touch